BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3510643)

  • 1. Intravenous captopril treatment in patients with severe cardiac failure.
    Rademaker M; Shaw TR; Williams BC; Duncan FM; Corrie J; Eglen A; Edwards CR
    Br Heart J; 1986 Feb; 55(2):187-90. PubMed ID: 3510643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous captopril in congestive heart failure.
    Ahmad S; Giles TD; Roffidal LE; Haney Y; Given MB; Sander GE
    J Clin Pharmacol; 1990 Jul; 30(7):609-14. PubMed ID: 2202753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of correlation between the acute haemodynamic response to intravenous captopril and plasma concentrations of angiotensin II in patients with chronic cardiac failure.
    Flapan AD; Shaw TR; Edwards CR; Rademaker M; Davies E; Williams BC
    Eur J Clin Pharmacol; 1992; 43(1):1-5. PubMed ID: 1505601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma free captopril concentrations during short and long term treatment with oral captopril for heart failure.
    Shaw TR; Duncan FM; Williams BC; Crichton E; Thomson SA; Davis JR; Rademaker M; Edwards CR
    Br Heart J; 1985 Aug; 54(2):160-5. PubMed ID: 3893490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemodynamics after sublingual administration of captopril in severe heart failure. A pilot study].
    Haude M; Steffen W; Erbel R; Tschollar W; Belz GG; Meyer J
    Dtsch Med Wochenschr; 1989 Jul; 114(28-29):1095-100. PubMed ID: 2663409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemodynamic effects of the intravenous administration of captopril in patients with chronic congestive heart failure].
    Volpini M; Gargano M; Cuccia C; Dei Cas L; Gei P; Metra M; Moretti R; Riva S
    Cardiologia; 1989 Jun; 34(6):517-23. PubMed ID: 2676168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrasting patterns of arterial and venous dilatation after intravenous captopril in patients with chronic cardiac failure and their relationship to plasma angiotensin II concentrations.
    Flapan AD; Shaw TR; Edwards CR; Davies E; Williams BC
    Am Heart J; 1992 Nov; 124(5):1270-6. PubMed ID: 1442495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Enhancement of the effect of captopril in the 1st 48 hours of treating refractory heart failure. A comparison with intravenous trinitrine].
    Le Pailleur C; Baubion N; Metzger JP; Heulin A; Vacheron A; Di Matteo J
    Arch Mal Coeur Vaiss; 1984 Jun; 77(6):700-6. PubMed ID: 6431936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of the optimal dose of captopril in the treatment of severe cardiac failure by hourly hemodynamic monitoring].
    Allal J; Pornin M; Rossi F; Poupet JY; Bordage JP; Barraine R
    Arch Mal Coeur Vaiss; 1984 Apr; 77(4):458-67. PubMed ID: 6426432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of captopril in heart failure complicating acute myocardial infarction and persistence of acute haemodynamic effects in chronic heart failure after 3 years of treatment.
    Mattioli G; Ricci S; Rigo R; Fusaro MT; Cappello C
    Postgrad Med J; 1986; 62 Suppl 1():164-6. PubMed ID: 3534855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between diuretic dose, and the haemodynamic response to captopril in patients with cardiac failure.
    Flapan AD; Davies E; Williams BC; Shaw TR; Edwards CR
    Eur Heart J; 1992 Jul; 13(7):971-5. PubMed ID: 1644090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute hemodynamics of pimobendan in chronic heart failure. A comparative crossover study of captopril and pimobendan.
    Tsuda T; Izumi T; Kodama M; Hanawa H; Takahashi M; Suzuki M; Aizaki T; Uchiyama H; Kuwano H; Shibata A
    Jpn Heart J; 1992 Mar; 33(2):193-203. PubMed ID: 1593749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative hemodynamic and neurohormonal effects of intravenous captopril and digoxin and their combinations in patients with severe heart failure.
    Gheorghiade M; Hall V; Lakier JB; Goldstein S
    J Am Coll Cardiol; 1989 Jan; 13(1):134-42. PubMed ID: 2562844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptomatic hemodynamic and hormonal effects of intravenous captopril in patients with heart failure.
    Wu H; Zhao HY
    Chin Med J (Engl); 1994 May; 107(5):342-6. PubMed ID: 7924573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone.
    Wenting GJ; Man in't veld AJ; Woittiez AJ; Boomsma F; Laird-Meeter K; Simoons ML; Hugenholtz PG; Schalekamp MA
    Br Heart J; 1983 Jan; 49(1):65-76. PubMed ID: 6336940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute and long-term effect of captopril in severe chronic heart failure].
    Kikis D; Heck I; Stumpe KO; Esser H
    Dtsch Med Wochenschr; 1985 Apr; 110(15):583-8. PubMed ID: 2983968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and haemodynamic effects of low dose captopril in severe chronic heart failure.
    Sharpe DN; Coxon RJ
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):161S-167S. PubMed ID: 6753897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A clinical study of intravenous captopril in heart failure].
    Wu H; Zhao HY
    Zhonghua Nei Ke Za Zhi; 1993 Mar; 32(3):161-4. PubMed ID: 8222978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic and neurohumoral response to exercise in patients with congestive heart failure treated with captopril.
    Creager MA; Faxon DP; Weiner DA; Ryan TJ
    Br Heart J; 1985 Apr; 53(4):431-5. PubMed ID: 3885981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The benefit of combined therapy with captopril and nitrates in severe congestive heart failure].
    Halon DA; Rosenfeld T; Hardoff R; Lewis BS
    Cardiology; 1994; 84 Suppl 1():43-51. PubMed ID: 8087824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.